Compare Medtronic PLC (MDT) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Warner Music Group Corp — how do they compare? Medtronic PLC trades at $82.72 (market cap $106.61B), while Warner Music Group Corp trades at $28.05 (market cap $14.64B). The key difference: Medtronic PLC is far larger — about 7.3× Warner Music Group Corp's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | WMG | |
|---|---|---|
Market Cap | $106.61B | $14.64B |
Sector | Health | Media |
52-Week High | $105.35 | $34.72 |
52-Week Low | $73.75 | $23.65 |
Enterprise Value | $125.36B | $18.84B |
Dividend Yield | 3.46% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Warner Music Group (WMG) trades at $28.08, down 0.88% on the day, with a bearish technical signal and mixed earnings history. Revenue growth is steady, reaching $6.71B in 2025, but net income margin has declined to 5.44%. Recent developments include a strategic renewal with NetEase Cloud Music and the acquisition of AI startup Sureel AI, enhancing IP monetization capabilities in the evolving music industry.
The stock offers a 44% upside to the consensus price target of $40.40, supported by strong analyst buy ratings (66.66%), but faces risks from competitive pressures and margin compression. Investors should weigh the high P/E ratio of 33.73 against growth initiatives and cash flow improvements projected for 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
